BD PharmingenTM PerCP-CyTM5.5 Mouse Anti-Human CD134

Description

Flow cytometric analysis of CD134 expression on stimulated human peripheral blood lymphocytes. Phytohemagglutinin-stimulated PHA; Sigma L-1668; 3 days peripheral blood mononuclear cells were stained with either PerCP-Cy5.5 Mouse Anti-Human CD134 antibody Cat. No. 563659; solid line histogram or with PerCP-Cy5.5 Mouse IgG1, kappa Isotype Control Cat. No. 550795; dashed line histogram . The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable lymphoblasts. Flow cytometric analysis was performed using a BD LSR II Flow Cytometer System. Flow cytometric analysis of CD134 expression on stimulated human peripheral blood lymphocytes. Phytohemagglutinin-stimulated PHA; Sigma L-1668; 3 days peripheral blood mononuclear cells were stained with either PerCP-Cy5.5 Mouse Anti-Human CD134 antibody Cat. No. 563659; solid line histogram or with PerCP-Cy5.5 Mouse IgG1, kappa Isotype Control Cat. No. 550795; dashed line histogram . The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable lymphoblasts. Flow cytometric analysis was performed using a BD LSR II Flow Cytometer System. Show More Flow cytometric analysis of CD134 expression on stimulated human peripheral blood lymphocytes. Phytohemagglutinin-stimulated PHA; Sigma L-1668; 3 days peripheral blood mononuclear cells were stained with either PerCP-Cy5.5 Mouse Anti-Human CD134 antibody Cat. No. 563659; solid line histogram or with PerCP-Cy5.5 Mouse IgG1, kappa Isotype Control Cat. No. 550795; dashed line histogram . The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable lymphoblasts. Flow cytometric analysis was performed using a BD LSR II Flow Cytometer System.